scholarly article | Q13442814 |
P356 | DOI | 10.1001/JAMA.1991.03470090059032 |
P698 | PubMed publication ID | 1870247 |
P2093 | author name string | T A Miettinen | |
T E Strandberg | |||
H T Vanhanen | |||
S J Sarna | |||
V A Naukkarinen | |||
V V Salomaa | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cardiovascular disease | Q389735 |
P304 | page(s) | 1225-1229 | |
P577 | publication date | 1991-09-01 | |
P1433 | published in | The Journal of the American Medical Association | Q1470970 |
P1476 | title | Long-term mortality after 5-year multifactorial primary prevention of cardiovascular diseases in middle-aged men. | |
P478 | volume | 266 |
Q42745043 | A butter diet induces higher levels of n-3 PUFA and of n-3/n-6 PUFA ratio in rat serum and hearts than a safflower oil diet |
Q43516984 | A longitudinal survey of the evolution of some cardiovascular risk factors during the careers of male firefighters retiring from Strathclyde Fire Brigade from 1985-1994. |
Q36806615 | Alternatives to placebo-controlled trials |
Q36652535 | Cardiovascular risk factors in perspective |
Q34185087 | Cholesterol concentrations in violent and non-violent women suicide attempters. |
Q72248265 | Cholesterol confusion in primary prevention of coronary artery disease |
Q50248129 | Cohort Profile: The Helsinki Businessmen Study (HBS). |
Q78106644 | Comparative effects of short- and long-term feeding of safflower oil and perilla oil on lipid metabolism in rats |
Q24247967 | Dietary advice given by a dietitian versus other health professional or self-help resources to reduce blood cholesterol |
Q51037940 | Doctor's Dilemma. |
Q37763196 | Does the blood pressure-lowering effect of statins contribute to their beneficial cardiovascular effects? |
Q77612402 | Effect of dietary oils enriched with n-3 fatty acids on survival of mice |
Q33942127 | Effectiveness of individual lifestyle interventions in reducing cardiovascular disease and risk factors. |
Q24239935 | First-line drugs for hypertension |
Q56336831 | First-line drugs for hypertension |
Q24198193 | General health checks in adults for reducing morbidity and mortality from disease |
Q67825792 | Guidelines for the management of hyperlipidaemia in general practice. Towards the primary prevention of coronary heart disease. Royal College of General Practitioners |
Q46207246 | Health promotion in general practice: Authors' reply: OXCHECK study |
Q43224575 | Hypercholesterolemia. Is the fat still in the fire? |
Q36232351 | Implications of recent results of long term multifactorial primary prevention of cardiovascular diseases |
Q57149849 | Increased Mortality Despite Successful Multifactorial Cardiovascular Risk Reduction in Healthy Men: 40-Year Follow-Up of the Helsinki Businessmen Study Intervention Trial |
Q44305198 | Lack of benefit of dietary advice to men with angina: results of a controlled trial |
Q40622781 | Metabolic consequences of dietary trans fatty acids |
Q36824647 | Mortality in participants and non-participants of a multifactorial prevention study of cardiovascular diseases: a 28 year follow up of the Helsinki Businessmen Study |
Q24234642 | Multiple risk factor interventions for primary prevention of coronary heart disease |
Q24243941 | Multiple risk factor interventions for primary prevention of coronary heart disease |
Q33560415 | Optimising the economic efficiency of drug studies |
Q34273046 | Oxidative stress in cardiovascular disease |
Q70557859 | Periodic health examination, 1993 update: 2. Lowering the blood total cholesterol level to prevent coronary heart disease. Canadian Task Force on the Periodic Health Examination |
Q38622305 | Pharmacotherapy for hypertension in adults aged 18 to 59 years. |
Q72345392 | Predictors of mortality in very old subjects aged 80 years or over |
Q42765540 | Preventing coronary heart disease |
Q34712987 | Prevention. How much harm? How much benefit? 4. The ethics of informed consent for preventive screening programs. |
Q34369977 | Preventive medicine in primary care: management of hyperlipidaemia |
Q34025127 | Primary prevention of heart disease and stroke: a simplified approach to estimating risk of events and making drug treatment decisions |
Q36138368 | Proof of concept in cardiovascular risk: the paradoxical findings in blood pressure and lipid abnormalities |
Q42578253 | Relation of coronary heart disease incidence and total mortality to plasma cholesterol reduction in randomised trials: use of meta-analysis |
Q34464265 | Relation of serum cholesterol, lipid, serotonin and tryptophan levels to severity of depression and to suicide attempts. |
Q84446947 | Searching for a predictive peripherical biological model in parasuicidal behaviour |
Q36904031 | Serum cholesterol concentrations in parasuicide |
Q42882148 | Serum cholesterol concentrations in parasuicide. No association between low cholesterol and violent death |
Q51088271 | Serum cholesterol, suicidal tendencies, impulsivity, aggression, and depression in adolescent psychiatric inpatients. |
Q51575122 | Short-term safety and efficacy of low-dose simvastatin in elderly patients with hypertensive hypercholesterolemia and fasting hyperinsulinemia. |
Q33560221 | Simvastatin: a pharmacoeconomic evaluation of its cost-effectiveness in hypercholesterolaemia and prevention of coronary heart disease |
Q33696196 | Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? |
Q93505997 | The cholesterol controversy |
Q68104943 | The cholesterol controversy |
Q33613238 | The fact and fiction of lowering cholesterol concentrations in the primary prevention of coronary heart disease |
Q40898416 | The independent roles of diet and serum lipids in the 20th-century rise and decline of coronary heart disease mortality |
Q43640943 | The quandary of experimental chemotherapy |
Q33941776 | Types of dietary fat and risk of coronary heart disease: a critical review |
Q36710736 | When it comes to lifestyle recommendations, more is sometimes less: a meta-analysis of theoretical assumptions underlying the effectiveness of interventions promoting multiple behavior domain change |
Q78236773 | [Primary nutritional and drug prevention of atherosclerosis] |
Search more.